ARTICLE | Distillery Therapeutics
Cardiovascular
December 13, 2017 1:15 AM UTC
Mouse studies suggest inhibiting ARHGEF1 could help treat atherosclerosis. In an LDLR-deficient mouse model of atherosclerosis, ARHGEF1 knockout decreased the formation of atherosclerotic lesions comp...
BCIQ Company Profiles
Institut National de la Sante et de la Recherche Medicale (INSERM)